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An association between mycosis fungoides (MF)
and neutrophilic dermatoses (ND) is rare. We
describe a case of long-duration stage IIB MF
developing pyoderma gangrenosum-like lesions
and neutrophilic hidradenitis with histologic find-
ings suggestive of necrotizing vasculitis.Fig 1. Painful nodules on the legs.CASE REPORT
We report the case of an 80-year-old woman with
MF diagnosed 30 years previously after the appear-
ance of a tumor on her right forearm which was
treated with radiotherapy (initial stage IIB). In the
following years, the patient periodically had plaques
on the trunk and extremities. These plaques were
controlled with psoraleneultraviolet A therapy
(PUVA-T). After 2 years in complete remission, she
presented with a new tumor on the neck. Histologic
examination confirmed tumoral MF without
transformation to large cell. Disseminated disease
was ruled out and chest, abdominal, and pelvic
computer tomography demonstrated no pathologic
findings. Serum lactate dehydrogenase levels were
normal. Treatment with PUVA-T was initiated with
good initial response for the first 3 months, then
painful nodules developed on the upper lip, scalp,
and legs that progressed rapidly toward ulceration
(Fig 1). Skin biopsy of the scalp lesion found
inflammatory infiltrate with predominance of neu-
trophils and eosinophils with associated neutrophilic
hidradenitis. Biopsy of one of the leg nodules found
syringotropic, atypical lymphoid infiltrate (Fig 2)
with CD3 and CD30 positivity and foci of necrotizing
vasculitis. The infiltrate was negative for CD4, CD7,the Departments of Dermatologya and Pathology,b Com-
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ail.com.CD8, CD20, CD56, Mum-1, and Epstein-Barr virus,
and no large cells were present (Fig 3). The T-cell
receptor gene rearrangement showed monoclonal-
ity. Cultures for bacteria, mycobacteria, and fungi
were negative. Test results for viral hepatitis, human
immunodeficiency virus, syphilis, antinuclear anti-
bodies, antineutrophil cytoplasmic antibodies, and
cryoglobulins were all negative. Protein electropho-
resis showed no alterations. PUVA-T was discontin-
ued, and treatment with prednisone, 30 mg/d, was
initiated with rapid resolution of lesions of scalp and
upper lip, but the leg lesions did not respond to
treatment. Prednisonewas increased to 45mg/dwithJAAD Case Reports 2015;1:333-6.
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Fig 2. Neutrophilic dermatosis associated with atypical lymphoid infiltrate (A). Neutrophilic
hidradenitis and syringotropic atypical lymphoid infiltrate (B). ND and necrotizing vasculitis (C).
(Hematoxilin-eosin stain.)
Fig 3. Atypical T lymphoid infiltrate. Immunohistochemical studies show expression of CD3
and CD30 (A and D) and loss of expression of CD4 and CD8 (B and C).
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weekly. Disease progression continued with the
appearance of new tumors on the legs, someulcerated, clinically similar to lesions of pyoderma
gangrenosum (Fig 4). Neutrophilia was evident in
the blood count. Another biopsy of a tumoral lesion
Fig 4. Evolution of the painful nodules into ulcerated
tumors, some of them clinically similar to pyoderma
gangrenosum.
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flammatory infiltrate with focal necrotizing vasculitis
and neutrophilic hidradenitis. A companion atypical
lymphoid infiltrate was evident. New total-body
computer tomography scan found the presence of
new masses in both adrenal glands, suggestive of
metastases. A fine-needle aspiration biopsy of one of
those lesions found the presence of atypical
lymphoid cells. Pathologic lymph nodes were not
found on clinical examination or in the tomography
images. Immunophenotyping of peripheral blood
T cells showed a monoclonal population \ 5%
CD31, CD41, and CD8. With the diagnosis of
neutrophilic dermatosis associated with stage IVB
MF, prednisone 40 mg/d was continued, the dose of
MTX was increased to 40 mg/wk, and bexarotene
300 mg/d was added. However, the patient’s status
rapidly deteriorated. She subsequently died of
acute respiratory failure 1 month after the diagnosis
of the ND.DISCUSSION
NDs are characterized by a neutrophilic inflam-
matory infiltrate in the absence of infectious dis-
ease. NDs may be associated with various systemic
diseases including inflammatory bowel disease and
rheumatic or hematologic diseases. Their relation-
ship with lymphoproliferative disease is known,
especially with acute leukemias.1 However, to our
knowledge there are only 5 reported cases of ND
associated with MF (Table I).2-4 The types of
neutrophilic dermatoses described in these cases
are diverse. There are cases of pyoderma gangre-
nosumlike lesions, neutrophilic hidradenitis,
Sweet’s syndrome, and exanthematous pustulosis.
In our case, the patient had pyoderma gangreno-
sumlike lesions, neutrophilic hidradenitis, andassociating histologic images suggestive of necro-
tizing vasculitis. The pathogenic mechanism that
causes activation of neutrophils in these cases is
unknown. A potential pathogenic role of
interleukin-8, which has been shown to induce
neutrophil recruitment and activation, and which
can be secreted by CD30 cells, has been pro-
posed.2,5 Another possible cause could be the use
of drugs such as IFN-alfa (IFN-a) that can act as an
inducer of granulocyte colony-stimulating factor
and neutrophils.2 Two of the published cases also
associated transformation to CD301 cells. We
believe that the diagnosis of MF in these cases
can be complex, as with pyogenic anaplastic
variant CD301 cutaneous lymphomas. In these
cases, the dense neutrophilic infiltration may
mask the lymphoid infiltrate.6 With the
exception of the case presented by Aubin et al,4
all cases, including ours, share a number of
features already described by Franck et al2: (1)
The development of neutrophilic dermatosis is
associated with poor prognosis, and all patients
died in an interval of between 6 weeks and
17 months. Interestingly, the final cause of death
in all patients was acute respiratory failure, but we
don’t know whether neutrophils played some
pathophysiologic role in the development of pul-
monary involvement. (2) There was a lack of
response to standard treatment of neutrophilic
dermatosis. (3) There was syringotropism of atyp-
ical lymphoid cells in the histologic study. The
pathophysiology of the association between MF
and development of neutrophilic dermatosis, how-
ever, remains unknown. Both treatment with IFN-a
and histologic transformation are causal theories
postulated to date. We failed to establish the
underlying cause because our patient did not
receive treatment with IFN-a, and histologic trans-
formation could not be demonstrated. We suggest
that it is possible that this association has been the
manifestation of a paraneoplastic phenomenon
associated with advanced lymphoproliferative
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